Refine by
Molecular Diagnostics Equipment Supplied In France
6 equipment items found
Manufactured by:ELITechGroup based inPuteaux, FRANCE
ELITe InGenius is an easy-to-use sample-to-result solution dedicated to Molecular Diagnostics which integrates extraction, amplification and result interpretation with an unprecedented flexibility and assay menu ...
Manufactured by:ELITechGroup based inPuteaux, FRANCE
Aspergillosis is the most common cause of fungal infection among stem cell and solid organ transplant recipients, resulting in high mortality if untreated. Patients with weakened immune system and lung diseases are at higher risk of developing severe outcomes. Early detection and quantification of Aspergillus with molecular methods is crucial to isolate infected patients and provide an ...
Manufactured by:ELITechGroup based inPuteaux, FRANCE
Pneumocystis pneumonia (PCP) is an opportunistic disease caused by invasion of the unicellular fungus Pneumocystis jirovecii (PJ). In lungs PJ exists in trophic and cystis form and it is one of the most frequent and severe opportunistic infections in people with weakened immune systems. PCP a major cause of morbidity and mortality among HIV-infected patient, nowadays reduced with ART, moreover, ...
Manufactured by:ELITechGroup based inPuteaux, FRANCE
Epstein-Barr Virus (EBV) is a widespread herpesvirus, generally asymptomatic or sometimes responsible for mild infection like mononucleosis. After solid organ or hematopoietic stem cell transplant, EBV reactivation is a common cause of malignant transformation, called Post-Transplant Lymphoproliferative Disorder “PTLD”. EBV viral load monitoring is important to diagnose, and monitor ...
Premium
Manufactured by:Bertin Technologies based inMontigny-le-Bretonneux, FRANCE
BEC SARS-CoV-2 RT-LAMP system is designed for the rapid detection of SARS-CoV-2 genome on the field, in less than 30 ...
Manufactured by:GENFIT based inLoos, FRANCE
Nonalcoholic steatohepatitis (NASH) remains largely underdiagnosed, as it carries no obvious symptoms in its early stages, and also because of the lack of widely available non-invasive tests specifically developed to diagnose the disease. The underdiagnosis of NASH represents a major unmet need, and is a barrier for identification of patients at higher risk for disease progression, who would be ...